Energy Secretary Tours Sandia Labs


???All Albuquerque Journal news products require a paid subscription
  • Why we charge
    ??? ABQJournal.com is free to Albuquerque Journal print newspaper 7-day subscribers. If you are a daily print subscriber, register here for free access to ABQJournal.com
    ???Customer Service or call 505-823-4400
    USE PAYPAL
    99 cents
    for access to today's ABQjournal and eJournal
  • ?
    Find username or password
    Remember Me for a Month

    Source: http://www.abqjournal.com/main/2012/01/26/news/energy-secretary-tours-sandia-labs.html

    google ice cream sandwich soulja boy jason campbell android ice cream sandwich shia labeouf teleprompter ashley greene

    SAP bullish on 2012 after record results (Reuters)

    FRANKFURT (Reuters) ? SAP, the world's biggest maker of business software, was upbeat on its topline growth this year citing its investment in new technologies and robust corporate spending.

    Investors have worried that they may have overestimated the resilience of corporate tech spending in a deteriorating global economy, especially after SAP's big rival Oracle Corp reported weak quarterly results last month.

    But there have been increasing signs that the outlook may not be as dim as some feared. IBM Corp, the world's largest technology services company, brimmed with confidence for 2012 as it posted strong results last week.

    "We have significant momentum going into 2012," SAP said on Wednesday as it published its full financial results for 2011.

    The German company expects operating profit will rise to 5.05-5.25 billion euros ($6.6-$6.8 billion) at constant currencies from a 40-year record level of 4.71 billion in 2011.

    SAP shares were down 0.2 percent at 44.32 euros by 1223 GMT, while the German blue-chip index was 0.7 percent lower.

    SAP had already reported a better-than-expected rise in fourth-quarter sales and profit on January 13.

    It attributed the strong performance to demand for its biggest software products and growing demand for its HANA offering, which allows companies to analyze business data quickly, and said it had won market share overall.

    "In the current environment, where growth is tough to come by, this is clearly an encouraging message," Citigroup analyst Charles Brennan said.

    CHASING THE CLOUD

    SAP said it expects its 2012 revenue from software and software-related services to rise by 10-12 percent in the full year from 11.35 billion euros in 2011.

    As much as 2 percentage points of that increase will be contributed by SuccessFactors, which SAP last month agreed to buy for $3.4 billion to keep up with rivals in the race for cloud-computing business.

    The U.S. acquisition will dampen earnings in 2012, reducing operating margin growth to about 0.10 percentage points, compared with 1.1 percentage points improvement recorded in 2011, co-Chief Executive Bill McDermott said.

    Even excluding the impact of the acquisition, margin growth will slow to 0.7 percentage points.

    "We think that SAP will continue to outperform into 2012," JP Morgan analysts said, citing fourth-quarter strength across regions and business divisions, resilient pricing and growing market share amid challenging conditions.

    SAP, based in Walldorf near Heidelberg, built its business on large, integrated software systems sold to many of the world's biggest companies, such as Apple, GE, McDonald's and Pepsi.

    Now it is also betting on its mobile and so-called in-memory databank technology, designed to make analytical software more powerful by accessing data stored locally on a chip instead of on a server, allowing it to cater to a wider variety of clients.

    And it sees revenue from the cloud business at 2 billion euros by 2015.

    "We are well positioned to exceed our 20 billion euros revenue target and reach a 35 percent operating margin in 2015," Chief Financial Officer Werner Brandt said.

    SAP has about 183,000 customers and bills itself as the world's leading provider of software for managing supply chains and customer relations.

    SAP, whose stock has gained about 10 percent over the past year, trades at about 14.5 times 12-month forward earnings, at a premium to Oracle's multiple of 11.4 and IBM at 12.7, according to ThomsonReuters StarMine data.

    ($1=0.7704 euros)

    (Reporting by Maria Sheahan; Editing by Dan Lalor and Mike Nesbit)

    Source: http://us.rd.yahoo.com/dailynews/rss/software/*http%3A//news.yahoo.com/s/nm/20120125/bs_nm/us_sap

    martyn ecri stacey dash the time machine cloverfield take shelter take shelter

    Jupiter?s 'Trojans' on an atomic scale

    ScienceDaily (Jan. 25, 2012) ? The planet Jupiter keeps asteroids on stable orbits -- and in a similar way, electrons can be stabilized in their orbit around the atomic nucleus. Calculations carried out at the Vienna University of Technology have now been verified in an experiment.

    Planets can orbit a star for billions of years. Electrons circling the atomic nucleus are often visualized as tiny planets. But due to quantum effects, the behavior of atoms usually differs significantly from planetary systems. Austrian and US-American scientists have now succeeded in keeping electrons on planet-like orbits for a long time. This was done using an idea from astronomy: Jupiter stabilizes the orbits of asteroids (the so called "Trojans"), and in a very similar way, the orbits of electrons around the nucleus can be stabilized using an electromagnetic field. The results of this experiment have now been published in the journal Physical Review Letters.

    Giant Atoms

    They are probably the largest atoms on earth: "The diameter of the electronic orbits is several hundredths of a millimeter -- an enormous distance on an atomic scale," says Shuhei Yoshida (Vienna UT). The atoms are even larger than erythrocytes. Yoshida made the calculations at Vienna University of Technology, the experiment was carried out at Rice University in Houston (Texas).

    The Electron is not a Planet

    The idea that atoms are similar to planetary systems dates back to Niels Bohr: he came up with the first atomic model, in which electrons circle the nucleus in well-defined orbits. This view, however, is now seen to be outdated. In quantum physics, the electron is described as a quantum wave, or a "probability cloud," that surrounds the atomic nucleus. The location of an electron in the ground state (the lowest possible energy level) is not well defined. Relative to the nucleus, it is situated in all possible directions at the same time. Asking about its "real position" or its orbit just does not make sense. Only if the electron is transferred into a state of higher energy, it can be manipulated in such a way that it moves along orbit-like paths.

    Jupiter's trick -- Used for the Atom

    Unlike planets, electrons will not keep moving in such an orbit for ever. "Without additional stabilization, the electron-wave would become delocalized after a few cycles," says Professor Joachim Burgd?rfer, head of the Institute for Theoretical Physics at Vienna UT. A simple idea on how to stabilize orbits has been known in astronomy for a long time: the gravity of Jupiter, the heaviest planet in our solar system, stabilizes the orbits of the "Trojans" -- thousands of small asteroids. They aggregate around so-called "Lagrange points" on Jupiter's orbital path. Staying close to these Lagrange points, the asteroids circle the sun together with the planet -- with exactly the same orbital velocity, so that the asteroids never collide with Jupiter.

    In the experiment, the stabilizing influence of Jupiter's gravity is substituted by a cleverly designed electromagnetic field. The field oscillates precisely with the frequency corresponding to the orbital period of the electron around the nucleus. It sets the pace for the electron, and that way the electron-wave is kept at a specific point for a long time -- much like a large number of asteroids, staying close to Jupiter's Lagrange points on their orbit around the sun. Quantum physics even allows manipulations which are impossible in a planetary system: using the electromagnetic field, the electron can by shifted into a different orbit -- as if the orbit of Jupiter and its asteroids was suddenly shifted to the orbit of Saturn.

    Big and Small

    The physicists succeeded in creating an atomic miniature version of a solar system and preparing atoms which are remarkably close to the historic Bohr model. In future, the researchers want to prepare atoms in which several electrons move on planetary orbits at the same time. Using such atoms, it should be possible to investigate in greater detail how the quantum-world of tiny objects corresponds to the classical world as we perceive it.

    Recommend this story on Facebook, Twitter,
    and Google +1:

    Other bookmarking and sharing tools:


    Story Source:

    The above story is reprinted from materials provided by Vienna University of Technology, TU Vienna, via AlphaGalileo.

    Note: Materials may be edited for content and length. For further information, please contact the source cited above.


    Journal Reference:

    1. B. Wyker, S. Ye, F. Dunning, S. Yoshida, C. Reinhold, J. Burgd?rfer. Creating and Transporting Trojan Wave Packets. Physical Review Letters, 2012; 108 (4) DOI: 10.1103/PhysRevLett.108.043001

    Note: If no author is given, the source is cited instead.

    Disclaimer: Views expressed in this article do not necessarily reflect those of ScienceDaily or its staff.

    Source: http://feeds.sciencedaily.com/~r/sciencedaily/~3/2pPjoxeYDaM/120125091057.htm

    apple iphone apple iphone chris christie cnet tampa bay rays netanyahu apple keynote

    Oscar prospects span the century as noms near (AP)

    BEVERLY HILLS, Calif. ? Prospective Academy Awards nominees have pretty much every decade of the last century covered, from the World War I epic "War Horse" through modern times with the family drama "The Descendants."

    In between at Tuesday morning's nominations are such contenders as the 1920s and `30s tales "The Artist" and "Hugo," the 1950s movie-making story "My Week with Marilyn," the 1960s Deep South drama "The Help," the 1970s Cold War thriller "Tinker Tailor Soldier Spy" and the Margaret Thatcher chronicle "The Iron Lady," spanning decades from her youth in World War II through her 1980s and `90s career as Britain's prime minister.

    The Oscar nominations will be announced by Jennifer Lawrence at a 10-minute, predawn ceremony at the headquarters of the Academy of Motion Picture Arts and Sciences.

    The best-picture prize on Oscar night could become a tussle between the top films at the Golden Globes: best drama recipient "The Descendants," starring George Clooney as a Hawaii father trying to keep his family together after a boating accident puts his wife in a coma; and best musical or comedy winner "The Artist," with Jean Dujardin as a silent-movie star whose career crumbles as talking pictures take over.

    Clooney and Dujardin, who won the lead-actor Globes in their respective categories, are likely best-actor nominees at the Oscars.

    Another performer with strong prospects is Globe dramatic actress winner Meryl Streep as Thatcher in "The Iron Lady." Two-time Oscar winner Streep would pad her record as the most-nominated actress, raising her total to 17 nominations, five more than Katharine Hepburn and Jack Nicholson, who are tied for second-place.

    Also in the running: Viola Davis and Octavia Spencer as Mississippi maids in "The Help"; Michelle Williams as Marilyn Monroe and Kenneth Branagh as Laurence Olivier in "My Week with Marilyn"; Leonardo DiCaprio as FBI boss J. Edgar Hoover in "J. Edgar"; Glenn Close as a woman masquerading as a male butler in "Albert Nobbs"; Brad Pitt as Oakland A's general manager Billy Beane in "Moneyball"; and Michael Fassbender as a sex addict in "Shame."

    Winners of the 84th annual Oscars will be announced at a Feb. 26 ceremony aired live on ABC from Hollywood's Kodak Theatre, with Billy Crystal returning as host for the first time in eight years.

    The most-beloved Oscar host of the last two decades, Crystal agreed to lead the show for the ninth time after Eddie Murphy bowed out in support of his pal, filmmaker Brett Ratner, who quit as Oscar producer amid the uproar over a gay slur he uttered in front of an audience at a screening of his and Murphy's comedy "Tower Heist."

    Crystal's return could bump up the TV ratings for the show, which have been on a general decline over the last couple of decades.

    What usually results in big TV ratings, though, is a blockbuster such as eventual Oscar champs "Titanic" or "The Lord of the Rings: The Return of the King" in the thick of the best-picture contest. More fans tune in because they have a stake in the outcome.

    But there are no colossal films such as that in the mix this time. "The Help" and best-picture longshot "Bridesmaids" are solid hits, both taking in about $170 million domestically, while "The Girl with the Dragon Tattoo" is closing on the $100 million mark. So far, other best-picture prospects are well under that level, ranging from $75 million for "Moneyball" to $12 million for "The Artist."

    ___

    David Germain reported from Park City, Utah.

    ___

    Online:

    http://www.oscars.org

    Source: http://us.rd.yahoo.com/dailynews/rss/topstories/*http%3A//news.yahoo.com/s/ap/20120124/ap_on_en_mo/us_oscar_nominations

    ama awards 2011 uekman uekman music awards music awards giants eagles bcs rankings week 13

    Pot-based prescription drug looks for FDA OK (AP)

    SAN FRANCISCO ? A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in marijuana, additional medicines derived from or inspired by the cannabis plant itself could soon be making their way to pharmacy shelves, according to drug companies, small biotech firms and university scientists.

    A British company, GW Pharma, is in advanced clinical trials for the world's first pharmaceutical developed from raw marijuana instead of synthetic equivalents_ a mouth spray it hopes to market in the U.S. as a treatment for cancer pain. And it hopes to see FDA approval by the end of 2013.

    Sativex contains marijuana's two best known components ? delta 9-THC and cannabidiol ? and already has been approved in Canada, New Zealand and eight European countries for a different usage, relieving muscle spasms associated with multiple sclerosis.

    FDA approval would represent an important milestone in the nation's often uneasy relationship with marijuana, which 16 states and the District of Columbia already allow residents to use legally with doctors' recommendations. The U.S. Drug Enforcement Administration categorizes pot as a dangerous drug with no medical value, but the availability of a chemically similar prescription drug could increase pressure on the federal government to revisit its position and encourage other drug companies to follow in GW Pharma's footsteps.

    "There is a real disconnect between what the public seems to be demanding and what the states have pushed for and what the market is providing," said Aron Lichtman, a Virginia Commonwealth University pharmacology professor and president of the International Cannabinoid Research Society. "It seems to me a company with a great deal of vision would say, `If there is this demand and need, we could develop a drug that will help people and we will make a lot of money.'"

    Possessing marijuana still is illegal in the United Kingdom, but about a decade ago GW Pharma's founder, Dr. Geoffrey Guy, received permission to grow it to develop a prescription drug. Guy proposed the idea at a scientific conference that heard anecdotal evidence that pot provides relief to multiple sclerosis patients, and the British government welcomed it as a potential way "to draw a clear line between recreational and medicinal use," company spokesman Mark Rogerson said.

    In addition to exploring new applications for Sativex, the company is developing drugs with different cannabis formulations.

    "We were the first ones to charge forward and a lot of people were watching to see what happened to us," Rogerson said. "I think we are clearly past that stage."

    In 1985, the FDA approved two drug capsules containing synthetic THC, Marinol and Cesamet, to ease side-effects of chemotherapy in cancer patients. The agency eventually allowed Marinol to be prescribed to stimulate the appetites of AIDS patients. The drug's patent expired last year, and other U.S. companies have been developing formulations that could be administered through dissolving pills, creams and skin patches and perhaps be used for other ailments.

    Doctors and multiple sclerosis patients are cautiously optimistic about Sativex. The National Multiple Sclerosis Society has not endorsed marijuana use by patients, but the organization is sponsoring a study by a University of California, Davis neurologist to determine how smoking marijuana compares to Marinol in addressing painful muscle spasms.

    "The cannabinoids and marijuana will, eventually, likely be part of the clinician's armamentarium, if they are shown to be clinically beneficial," said Timothy Coetzee, the society's chief research officer. "The big unknown in my mind is whether they are clearly beneficial."

    Opponents and supporters of crude marijuana's effectiveness generally agree that more research is needed. And marijuana advocates fear that the government will use any new prescription products to justify a continued prohibition on marijuana use. .

    "To the extent that companies can produce effective medication that utilizes the components of the plant, that's great. But that should not be the exclusive access for people who want to be able to use medical marijuana," Americans for Safe Access spokesman Kris Hermes said. "That's the race against time, in terms of how quickly can we put pressure on the federal government to recognize the plant has medical use versus the government coming out with the magic bullet pharmaceutical pill."

    Interest in new and better marijuana-based medicines has been building since the discovery in the late 1980s and 1990s that mammals have receptors in their central nervous systems, several organs and immune systems for the chemicals in botanical cannabis and that their bodies also produce natural cannabinoids that work on the same receptors.

    One of the first drugs to build on those breakthroughs was an anti-obesity medication that blocked the same chemical receptors that trigger the munchies in pot smokers. Under the name Acomplia, it was approved throughout Europe and heralded as a possible new treatment for smoking cessation and metabolic disorders that can lead to heart attacks.

    The FDA was reviewing its safety as a diet drug when follow-up studies showed that people taking the drug were at heightened risk of suicide and other psychiatric disorders. French manufacturer Sanofi-Aventis, pulled it from the market in late 2008.

    Given that drug companies already were reluctant "to touch anything that is THC-like with a 10-foot- pole," the setback had a chilling effect on cannabinoid drug development, according to Lichtman.

    "Big companies like Merck and Pfizer were developing their own versions (of Acomplia), so all of those programs they spent millions and millions on just went away..." he said.

    But scientists and drug companies that are exploring pot's promise predict the path will ultimately be successful, if long and littered with setbacks.

    One is Alexandros Makriyannis, director of the Center for Drug Discovery at Northeastern University and founder of a small Boston company that hopes to market synthetic pain products that are chemically unrelated to marijuana, but work similarly on the body or inhibit the cannabinoid receptors. He also has been working on a compound that functions like the failed Acomplia but without the depressive effects.

    "I think within five to 10 years, we should get something," Makriyannis said.

    Source: http://us.rd.yahoo.com/dailynews/rss/biotech/*http%3A//news.yahoo.com/s/ap/20120122/ap_on_re_us/us_marijuana_drug_development

    vaclav havel kim jong ii dead snapdragon snapdragon kim jong ill dead wedding crashers next iron chef

    Romney and Gingrich clash in Florida debate (AP)

    TAMPA, Fla. ? A newly aggressive Mitt Romney charged in campaign debate Monday night that Newt Gingrich "resigned in disgrace" from Congress after four years as speaker and then spent the next 15 years "working as an influence peddler" in Washington.

    Gingrich shot back that Romney's attacks were riddled with falsehoods, and he referred to statements by two men who ran against Romney in 2008 in contending the former Massachusetts governor "can't tell the truth."

    The clash occurred in the opening moments of the first of this week's two debates before the Jan. 31 Florida primary.

    Gingrich trounced Romney in last Saturday's South Carolina contest, an upset that reset the race to pick a rival to President Barack Obama in the fall.

    Former Pennsylvania Sen. Rick Santorum and Texas Rep. Ron Paul shared the debate stage.

    Asked if he could envision a path to the nomination for himself, Santorum said the race has so far been defined by its unpredictability. He conceded he had been defeated for re-election in 2006 in Pennsylvania but said the party lost the governorship by an even bigger margin than his own defeat.

    "There's one thing worse than losing an election and that's not standing for the principles that you hold," he said, a comment he frequently makes while campaigning in an attempt to question Romney's commitment to conservatism.

    Paul sidestepped when moderator Brian Williams of NBC asked if he would run as a third-party candidate in the fall if he doesn't win the nomination. "I have no intention," he said, but he didn't slam the door.

    The polls post-South Carolina show Gingrich and Romney leading in the Florida primary. That and the former speaker's weekend victory explained why the two were squabbling even before the debate began.

    Romney began airing a harshly critical new campaign ad and said the former House speaker had engaged in "potentially wrongful activity" with the consulting work he did after leaving Congress in the late 1990s.

    Gingrich retorted that Romney was a candidate who was campaigning on openness yet "has released none of his business records."

    He followed up two hours before the debate by arranging the release of a contract his former consulting firm had with the Federal Home Loan Mortgage Corp. for a retainer of $25,000 per month in 2006, or a total for the year of $300,000. The agreement called for "consulting and related services."

    Despite Romney's attempts to call Gingrich a lobbyist, the contract makes no mention of lobbying.

    Increasingly, the race for the nomination appeared to be a two-way competition between the former Massachusetts governor and the one-time speaker of the House.

    After relying on allies to make most of the attacks on his rivals earlier in the campaign, Romney unleashed a commercial that went straight at Gingrich.

    "While Florida families lost everything in the housing crisis, Newt Gingrich cashed in," the TV ad says, noting that the former speaker made more than $1.6 million working for Freddie Mac. "Gingrich resigned from Congress in disgrace and then cashed in as a D.C. insider."

    Gingrich never registered as a lobbyist, but said he was a consultant for Freddie Mac, the federally backed mortgage company that played a significant role in the housing crisis.

    It remains to be seen if Romney can effectively use his newly aggressive stance on the debate stage, a forum in which Gingrich has excelled so far. Underfunded and overmatched by Romney's massive ground game across the country, Gingrich has relied upon strong debate performances to build support.

    It appears Romney has brought in outside help to improve his debate technique.

    Veteran debate coach Brett O'Donnell was spotted at a Romney campaign stop on Monday. He previously advised President George W. Bush and GOP nominee John McCain and was a senior adviser and speech writer for Michele Bachmann's abbreviated campaign.

    Gingrich showed no signs of backing down.

    During an appearance on ABC's "Good Morning America," he referred to Romney as "somebody who has released none of his business records, who has decided to make a stand on transparency without being transparent." After initially balking, Romney is set to release personal tax records on Tuesday

    Source: http://us.rd.yahoo.com/dailynews/rss/politics/*http%3A//news.yahoo.com/s/ap/20120124/ap_on_el_ge/us_republicans_debate

    katy perry divorce the curious case of benjamin button christine christine brock lesnar retires new years wake forest

    Queen's study finds religion helps us gain self-control

    [ Back to EurekAlert! ] Public release date: 24-Jan-2012
    [ | E-mail | Share Share ]

    Contact: Anne Craig
    anne.craig@queensu.ca
    613-533-2877
    Queen's University

    Thinking about religion gives people more self-control on later, unrelated tasks

    Thinking about religion gives people more self-control on later, unrelated tasks; according to results from a series of recent Queen's University study.

    "After unscrambling sentences containing religiously oriented words, participants in our studies exercised significantly more self-control," says psychology graduate student and lead researcher on the study, Kevin Rounding.

    Study participants were given a sentence containing five words to unscramble. Some contained religious themes and others did not. After unscrambling the sentences, participants were asked to complete a number of tasks that required self-control enduring discomfort, delaying gratification, exerting patience, and refraining from impulsive responses.

    Participants who had unscrambled the sentences containing religious themes had more self-control in completing their tasks.

    "Our most interesting finding was that religious concepts were able to refuel self-control after it had been depleted by another unrelated task," says Mr. Rounding. "In other words, even when we would predict people to be unable to exert self-control, after completing the religiously themed task they defied logic and were able to muster self-control."

    "Until now, I believed religion was a matter of faith; people had little 'practical' use for religion," Mr. Rounding explains. "This research actually suggests that religion can serve a very useful function in society. People can turn to religion not just for transcendence and fears regarding death and an after-life but also for practical purposes."

    Other members of the research team include psychology graduate student Albert Lee and Queen's professors Jill Jacobson and Li-Jun Ji. The study was published in Psychological Science.

    ###


    [ Back to EurekAlert! ] [ | E-mail | Share Share ]

    ?


    AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


    [ Back to EurekAlert! ] Public release date: 24-Jan-2012
    [ | E-mail | Share Share ]

    Contact: Anne Craig
    anne.craig@queensu.ca
    613-533-2877
    Queen's University

    Thinking about religion gives people more self-control on later, unrelated tasks

    Thinking about religion gives people more self-control on later, unrelated tasks; according to results from a series of recent Queen's University study.

    "After unscrambling sentences containing religiously oriented words, participants in our studies exercised significantly more self-control," says psychology graduate student and lead researcher on the study, Kevin Rounding.

    Study participants were given a sentence containing five words to unscramble. Some contained religious themes and others did not. After unscrambling the sentences, participants were asked to complete a number of tasks that required self-control enduring discomfort, delaying gratification, exerting patience, and refraining from impulsive responses.

    Participants who had unscrambled the sentences containing religious themes had more self-control in completing their tasks.

    "Our most interesting finding was that religious concepts were able to refuel self-control after it had been depleted by another unrelated task," says Mr. Rounding. "In other words, even when we would predict people to be unable to exert self-control, after completing the religiously themed task they defied logic and were able to muster self-control."

    "Until now, I believed religion was a matter of faith; people had little 'practical' use for religion," Mr. Rounding explains. "This research actually suggests that religion can serve a very useful function in society. People can turn to religion not just for transcendence and fears regarding death and an after-life but also for practical purposes."

    Other members of the research team include psychology graduate student Albert Lee and Queen's professors Jill Jacobson and Li-Jun Ji. The study was published in Psychological Science.

    ###


    [ Back to EurekAlert! ] [ | E-mail | Share Share ]

    ?


    AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


    Source: http://www.eurekalert.org/pub_releases/2012-01/qu-qsf012412.php

    howard hughes alcatraz kim richards scott walker recall cruise ship derek fisher martin luther king jr.

    Who's the Biggest Spender in the GOP Primary? (ABC News)

    Reese Witherspoon Will Answer Your Questions For 'MTV First'

    FROM MTV MOVIES: Reese Witherspoon, the star of the upcoming action-comedy "This Means War," could answer your question on MTV. All you have to do is ask it. It will all happen Tuesday, January 31st on MTV and MTV.com. MTV News' Josh Horowitz will sit down with the Academy Award-winning actress for an interview and premiere [...]

    Source: http://moviesblog.mtv.com/2012/01/23/reese-witherspoon-mtv-first/

    hillary clinton digestive system solon rhetoric npr supernova obama approval rating

    Kevin Federline Hospitalized In Australia With Chest Pains

    Britney Spears’ ex-husband Kevin Federline has been hospitalized in Australia after suffering chest pains while filming a fitness TV show. The former dancer has been taking part in weight-loss reality series Excess Baggage and he fell sick after completing a training session with Australian Football League team the Greater Western Giants in Sydney on Monday. [...]

    Source: http://www.celebritymound.com/kevin-federline-hospitalized-in-australia-with-chest-pains/?utm_source=rss&utm_medium=rss&utm_campaign=kevin-federline-hospitalized-in-australia-with-chest-pains

    2012 golden globe nominations houston texans houston texans texans enemy of the state lana del rey snl golden globe nominees